glioblastoma multiforme

Bristol-Myers' Opdivo fails late-stage brain cancer trial
Bristol-Myers' Opdivo fails late-stage brain cancer trial
Yahoo/Reuters
Bristol-Myers Squibb
Opdivo
clinical trials
glioblastoma multiforme
Flag link:
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
CP Wire
Enterome
immuno-oncology
glioblastoma multiforme
molecular mimicry
Flag link:
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Enterome
immuno-oncology
glioblastoma multiforme
Flag link:
Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Drug Delivery Business News
Novocure
Optune
glioblastoma multiforme
Flag link:
Novogen irons out Phase 2 plans for brain cancer candidate
Novogen irons out Phase 2 plans for brain cancer candidate
BioPharma Dive
Novagen
clinical trials
GDC-0084
glioblastoma multiforme
brain cancer
Flag link:
Tracon Tanks on Brain Cancer Drug Failure
Tracon Tanks on Brain Cancer Drug Failure
Investopedia
TRACON Pharmaceuticals
glioblastoma multiforme
brain cancer
TRC105
Flag link:
Northwest Bio Spikes on Lifting of Clinical Hold
Northwest Bio Spikes on Lifting of Clinical Hold
Investopedia
Northwest Biotherapeutics
DCVax-L
glioblastoma multiforme
brain cancer
Flag link:
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
TheStreet.com
Celldex Therapeutics
clinical trials
Rintega
glioblastoma multiforme
Flag link:
NovoCure’s cancer therapy effective in late-stage study
NovoCure’s cancer therapy effective in late-stage study
Mass Device
Novocure
Optune
brain cancer
glioblastoma multiforme
devices
Flag link:
Celldex vaccine improves long-term brain cancer survival in study
Celldex vaccine improves long-term brain cancer survival in study
Yahoo/Reuters
Celldex
vaccines
brain cancer
glioblastoma multiforme
Rintega
Flag link:
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
Flag link:
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
Fierce Biotech
ASCO
Celldex
glioblastoma multiforme
brain cancer
Rintega
Flag link:
Novogen Makes Big Step In Fighting Brain Cancer
Novogen Makes Big Step In Fighting Brain Cancer
24/7 Wall St
Novogen
TRXE-009
glioblastoma multiforme
brain cancer
Flag link:
Celldex Therapeutics To Enter Talks With FDA
Celldex Therapeutics To Enter Talks With FDA
Seeking Alpha
Celldex Therapeutics
FDA
GBM
rindopepimut
glioblastoma multiforme
Flag link:
FDA grants orphan drug designation to potential Insys brain cancer treatment
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Insys
orphan drugs
FDA
CBD
glioblastoma multiforme
Flag link:
AbbVie makes inroads in orphan drugs
AbbVie makes inroads in orphan drugs
Medical Marketing and Media
AbbVie
orphan drugs
glioblastoma multiforme
ABT-414
Flag link:
Northwest Bio DC-Vax Study Changes Hint at Failure
Northwest Bio DC-Vax Study Changes Hint at Failure
TheStreet.com
Northwest Biotherapeutics
DCVax
vaccines
glioblastoma multiforme
Flag link:
Agenus brain cancer vaccine nearly doubles survival rate in study
Agenus brain cancer vaccine nearly doubles survival rate in study
Yahoo/Reuters
Agenus
brain cancer
vaccines
glioblastoma multiforme
Flag link:
AbbVie heralds early success with its brain cancer-fighting armed antibody
AbbVie heralds early success with its brain cancer-fighting armed antibody
Fierce Biotech
glioblastoma multiforme
ABT-414
AbbVie
Flag link:
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
TheStreet.com
FDA
Northwest Biotherapeutics
glioblastoma multiforme
DCVax
Flag link:

Pages